| twenty-year trends in the incidence and prevalence of diagnosed anogenital warts in canada. | a vaccine has recently been licensed in many countries that protects against the human papillomavirus types 6, 11, 16, and 18. types 6 and 11 account for approximately 90% of anogenital warts (agws). we describe the 20-year trends in the incidence and prevalence of agws in manitoba, canada. | 2009 | 19556932 |
| the manitoba human papillomavirus vaccine surveillance and evaluation system. | with the recent introduction of a human papillomavirus (hpv) vaccine in canada, it is important to establish surveillance and evaluation programs that not only track the uptake of the vaccine, but also assess its safety and its impact on: distribution of hpv type, cervical cancer screening programs, the incidence of anogenital warts, precancerous lesions and various cancers, and sexual behaviour. | 2010 | 20632523 |